Episurf posted 1Q19 revenue of SEK 1.4MM (USD $0.2MM), +29.4% vs. 1Q18.
- Gross order intake increased 25.5% vs previous year
- Order backlog doubled to $0.1MM vs previous year
- Received new patent approvals in Australia, Japan, Canada and the U.S. so far in 2019
- Reached milestone 500th Episealer knee implant in Q1 2019
Segment sales and growth on an as-reported basis is as follows ($MM).
1Q19 | 1Q18 | $ Chg | % Chg | |
Joint Replacement, Knees | $0.2 | $0.1 | $0.0 | 29.4% |
Sources: Episurf
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
Episurf posted 1Q19 revenue of SEK 1.4MM (USD $0.2MM), +29.4% vs. 1Q18.
Gross order intake increased 25.5% vs previous year
Order backlog doubled to $0.1MM vs previous year
Received new patent approvals in Australia, Japan, Canada and the U.S. so far in 2019
Reached milestone 500th Episealer knee implant in Q1 2019
...
Episurf posted 1Q19 revenue of SEK 1.4MM (USD $0.2MM), +29.4% vs. 1Q18.
- Gross order intake increased 25.5% vs previous year
- Order backlog doubled to $0.1MM vs previous year
- Received new patent approvals in Australia, Japan, Canada and the U.S. so far in 2019
- Reached milestone 500th Episealer knee implant in Q1 2019
Segment sales and growth on an as-reported basis is as follows ($MM).
1Q19 | 1Q18 | $ Chg | % Chg | |
Joint Replacement, Knees | $0.2 | $0.1 | $0.0 | 29.4% |
Sources: Episurf
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.